Overview

A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
Phase:
PHASE1
Details
Lead Sponsor:
Kailera